In Aftermath of NEJM Article, Critic Bailar Declares The Defeat Of Cancer Treatment
In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse
In This Issue: The controversy Over “Cancer Undefeated”
“Imaginary Treatments,” “Wonderful Cures”
Call to Shift Two-Thirds Of Funds a “Rubber Number,” Bailar Says
Broder Says No Thanks To Acknowledgement For Paper’s Title
Letters to The Editors: Donald Coffey Finds Sensationalism Hurts
Ellen Stoval Calls For More Funding for All Cancer Research
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says
